ATTR AMYLOIDOSIS
Clinical trials for ATTR AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new ATTR AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for ATTR AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New PET scan could spot rare heart disease faster
Diagnosis Recruiting nowThis study tests whether a special PET scan using a radioactive tracer called [18F]Florbetaben can accurately diagnose cardiac AL amyloidosis, a rare condition where abnormal proteins build up in the heart. About 200 adults with suspected cardiac amyloidosis will receive one inje…
Matched conditions: ATTR AMYLOIDOSIS
Phase: PHASE3 • Sponsor: Life Molecular Imaging GmbH • Aim: Diagnosis
Last updated May 26, 2026 08:32 UTC
-
Massive new study to map ATTR amyloidosis journeys in over 52,000 patients
Knowledge-focused Recruiting nowThis study is observing over 52,000 people with ATTR amyloidosis to learn about their disease from diagnosis through treatment. Researchers will collect information from medical records to see how the disease progresses, what treatments are used, and how it affects quality of lif…
Matched conditions: ATTR AMYLOIDOSIS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 26, 2026 09:11 UTC
-
New italian registry aims to unlock secrets of rare amyloidosis
Knowledge-focused Recruiting nowThis study is building a large online registry of 1,000 people with ATTR amyloidosis, a rare disease where abnormal proteins build up in organs. Researchers will collect information from diagnosis through follow-up to better understand how the disease progresses in real life. The…
Matched conditions: ATTR AMYLOIDOSIS
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated May 26, 2026 09:09 UTC
-
Massive global study tracks rare disease over time
Knowledge-focused Recruiting nowThis study follows 1,500 people with ATTR amyloidosis, a rare disease where abnormal proteins build up in the body. Researchers will track how the disease progresses and how well current treatments work in everyday medical practice. The goal is to better understand the condition …
Matched conditions: ATTR AMYLOIDOSIS
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC